BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND XPO1, DKFZp686B1823, 7514, ENSG00000082898, O14980, CRM1 AND Prognosis
8 results:

  • 1. Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma.
    Deutzmann A; Sullivan DK; Dhanasekaran R; Li W; Chen X; Tong L; Mahauad-Fernandez WD; Bell J; Mosley A; Koehler AN; Li Y; Felsher DW
    Nat Commun; 2024 Feb; 15(1):963. PubMed ID: 38302473
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer.
    He Y; Mei J; Hao H; Liu F; Yi Y; Hu C; Zou F; Lu X
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):6931-6941. PubMed ID: 36840755
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma.
    Chen L; Huang Y; Zhou L; Lian Y; Wang J; Chen D; Wei H; Huang M; Huang Y
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31371628
    [No Abstract]    [Full Text] [Related]  

  • 4. MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.
    Li P; Ou Q; Braciak TA; Chen G; Oduncu FS
    Jpn J Clin Oncol; 2018 Jul; 48(7):619-624. PubMed ID: 29529220
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors.
    Vivaldi C; Caparello C; Musettini G; Pasquini G; Catanese S; Fornaro L; Lencioni M; Falcone A; Vasile E
    Int J Cancer; 2016 Aug; 139(4):938-45. PubMed ID: 27038273
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic value of crm1 in pancreas cancer.
    Huang WY; Yue L; Qiu WS; Wang LW; Zhou XH; Sun YJ
    Clin Invest Med; 2009 Dec; 32(6):E315. PubMed ID: 20003838
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Role of HSP90, CDC37, and crm1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
    Pascale RM; Simile MM; Calvisi DF; Frau M; Muroni MR; Seddaiu MA; Daino L; Muntoni MD; De Miglio MR; Thorgeirsson SS; Feo F
    Hepatology; 2005 Dec; 42(6):1310-9. PubMed ID: 16317707
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition.
    Feo F; De Miglio MR; Simile MM; Muroni MR; Calvisi DF; Frau M; Pascale RM
    Biochim Biophys Acta; 2006 Apr; 1765(2):126-47. PubMed ID: 16216419
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.